Lambert–Eaton myasthenic syndrome: Search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis
- 25 July 2008
- journal article
- review article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 201, 145-152
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Autoantibodies against M1 muscarinic acetylcholine receptor in myasthenic disordersEuropean Journal of Neurology, 2007
- Mechanisms Underlying the Rapid Induction and Sustained Expression of Synaptic HomeostasisNeuron, 2006
- HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert–Eaton myasthenic syndromeJournal of Neuroimmunology, 2005
- The action of Lambert–Eaton myasthenic syndrome immunoglobulin G on cloned human voltage‐gated calcium channelsMuscle & Nerve, 2002
- Presynaptic neuronal antigens expressed by a small cell lung carcinoma cell lineJournal of Neuroimmunology, 2001
- Antigens Associated with N‐ and L‐Type Calcium Channels in Lambert‐Eaton Myasthenic SyndromeJournal of Neurochemistry, 1995
- Expression of synaptotagmin and syntaxin associated with N‐type calcium channels in small cell lung cancerFEBS Letters, 1993
- Muscarinic Receptor SubtypesAnnual Review of Pharmacology and Toxicology, 1990
- Increased frequency of IgG heavy chain marker Glm(2) and HLA-B8 in Lambert-Eaton myasthenic syndrome with and without associated lung carcinomaHuman Immunology, 1985
- BRONCHIAL NEOPLASM WITH MYASTHENIA PROLONGED APN$OElig;A AFTER ADMINISTRATION OF SUCCINYLCHOLINEThe Lancet, 1953